These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 15779434)

  • 1. [Cognitive behavior therapy for impaired glucose tolerance].
    Shigeta M; Nakazawa A; Ozasa K
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():521-4. PubMed ID: 15779434
    [No Abstract]   [Full Text] [Related]  

  • 2. [Assessment of quality of life in patients with diabetes mellitus and impaired glucose tolerance].
    Wang W; Shi L; Wang K
    Zhonghua Yu Fang Yi Xue Za Zhi; 2001 Jan; 35(1):26-9. PubMed ID: 11860955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes or impaired glucose tolerance: does the label matter?
    Lara C; Ponce de Leon S; Foncerrada H; Vega M
    Diabetes Care; 2007 Dec; 30(12):3029-30. PubMed ID: 17728483
    [No Abstract]   [Full Text] [Related]  

  • 4. [Impaired glucose tolerance in the elderly--prevalence, pathogenesis and management].
    Ito H
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():341-4. PubMed ID: 15779400
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of daily exercise in prevention of impaired glucose tolerance].
    Ryomoto KI; Yamasaki Y
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():224-7. PubMed ID: 15779376
    [No Abstract]   [Full Text] [Related]  

  • 6. [Factors influencing occurrence of diabetes: eating behavior].
    Sato J
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():215-9. PubMed ID: 15779374
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevalence of diabetes mellitus and impaired glucose tolerance in a rural Palestinian population.
    Husseini A; Abdul-Rahim H; Awartani F; Jervell J; Bjertness E
    East Mediterr Health J; 2000; 6(5-6):1039-45. PubMed ID: 12197326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical significant of intervention of impaired glucose tolerance and some problems in the treatment].
    Xu ZR
    Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1765-7. PubMed ID: 15631768
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of impaired fasting glucose and impaired glucose tolerance on the progression of diabetic macroangiopathy].
    Igarashi M; Tominaga M
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():55-60. PubMed ID: 15779345
    [No Abstract]   [Full Text] [Related]  

  • 10. Impaired fasting glucose and impaired glucose tolerance: implications for care.
    Nathan DM; Davidson MB; DeFronzo RA; Heine RJ; Henry RR; Pratley R; Zinman B;
    Diabetes Care; 2007 Mar; 30(3):753-9. PubMed ID: 17327355
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cost-effectiveness of the diabetes prevention program for patients with IGT].
    Ikeda S; Kobayashi M
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():659-63. PubMed ID: 15779458
    [No Abstract]   [Full Text] [Related]  

  • 12. The potential for lifestyle change to influence the progression of impaired glucose tolerance to non-insulin-dependent diabetes mellitus.
    Bourn DM
    Diabet Med; 1996 Nov; 13(11):938-45. PubMed ID: 8946151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting-enzyme inhibitors for impaired glucose tolerance--is there still hope?
    Ingelfinger JR; Solomon CG
    N Engl J Med; 2006 Oct; 355(15):1608-10. PubMed ID: 16980381
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment for patients with impaired glucose tolerance].
    Tawaramoto K; Kaku K
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():423-7. PubMed ID: 15779416
    [No Abstract]   [Full Text] [Related]  

  • 15. A lifestyle intervention study in patients with diabetes or impaired glucose tolerance: translation of a research intervention into practice.
    Matvienko OA; Hoehns JD
    J Am Board Fam Med; 2009; 22(5):535-43. PubMed ID: 19734400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired glucose tolerance and impaired fasting glucose.
    Rao SS; Disraeli P; McGregor T
    Am Fam Physician; 2004 Apr; 69(8):1961-8. PubMed ID: 15117017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathophysiology and management of impaired glucose tolerance and diabetes with metabolic syndrome].
    Ohara T
    Nihon Rinsho; 2006 Dec; 64 Suppl 9():428-32. PubMed ID: 17458257
    [No Abstract]   [Full Text] [Related]  

  • 18. [Management of impaired glucose tolerance: physical training therapy].
    Sato Y; Sato J; Tokudome S
    Nihon Rinsho; 1996 Oct; 54(10):2745-9. PubMed ID: 8914438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Follow-up system within industrial corporations for patients with glucose intolerance].
    Atsumi Y
    Nihon Rinsho; 1996 Oct; 54(10):2761-4. PubMed ID: 8914441
    [No Abstract]   [Full Text] [Related]  

  • 20. [IFG and IGT in Europe and America: the present and prospective].
    Tsujii S; Kuzuya H
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():27-33. PubMed ID: 15779341
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.